The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment
Event:
EuroEcho-Imaging 2024
Topic:
Myocardial Disease
Session:
Imaging of the hypertrophied left ventricle
/f/125658/5000x1496/8aa45c8224/eacvi-acronym-text-rgb.png)
